Acumen Pharmaceuticals (ABOS) Quick Ratio

Acumen Pharmaceuticals, Inc. (ABOS) - corporate logo

The price history of Acumen Pharmaceuticals (ABOS) on the GURU.Markets platform is currently at 1.91. The business relies on exclusive antibody patents, overcoming the colossal costs and risks associated with clinical trials. Acumen Pharmaceuticals (ABOS) seeks market dominance through the development of ACU193 to combat Alzheimer's. Leading US clinics provide the patient inflow under strict FDA oversight.

Acumen Pharmaceuticals, Inc (ABOS) - Quick Liquidity Indicator from 07/04/2022 to 10/29/2026
Manufactured product of acumenpharm.com

This indicator measures immediate solvency by comparing cash and accounts receivable against short-term liabilities, excluding inventory. An analysis of the quick ratio allows for an assessment of the financial stability of Acumen Pharmaceuticals (ABOS) within the antibody development cycle, where the absence of inventory makes this calculation decisive for securing ongoing clinical trials.

Key competitors

Biogen Corp (BIIB) - Quick Liquidity|Immediate Liquidity Neurocrine Corp (NBIX)|RGC (Regencell Bioscience) - Quick Ratio|Quick Ratio axsome.com|Quick Ratio ACAD|Quick Liquidity Indicator Xenon Pharmaceuticals Inc. XENE|Viking Pharma - Quick Liquidity Indicator|Quick Ratio Supernus Corp SUPN|CPRX - Quick Liquidity|denalitherapeutics.com (DNLI) - Quick Liquidity Indicator|HRMY: Quick Ratio|Immediate Liquidity Biohaven Ltd (BHVN)|Quick Liquidity Amylyx|Immediate Liquidity Ratio TRVI (Trevi Corp)|Quick Liquidity Indicator PRAX (Praxis Precision Medicines)|AVXL (anavex.com) - Intermediate Coverage Ratio|Quick Liquidity CeriBell CBLL|PRTA (Prothena Corp) - Critical Liquidity Ratio|Alector Therapeutics - Quick Ratio|Intermediate Coverage Ratio ANNX (Annexon Biosciences Inc.)|OMER: Quick Ratio|neurogene.com (NGNE) - Quick Ratio|Quick Liquidity AC Immune SA|VYGR: Intermediate Coverage Ratio|Quick Liquidity Neumora Therapeutics Inc (NMRA)|Quick Liquidity Indicator Scilex Holding Company, Inc. SCLX|Quick Ratio TVGN (Tevogen Bio Holdings)|Quick Ratio Alpha Cognition Inc ACOG|Cognition Therapeutics - Quick Ratio|Inhibikase Therapeutics Inc (IKT) - Quick Liquidity Indicator|SAVA: Quick Ratio|Immediate Liquidity Assertio (ASRT)|Quick Liquidity Indicator COYA|Quick Ratio VistaGen Therapeutics Inc|Quick Liquidity Indicator OVID (Ovid Therapeutics Inc.)|Intermediate Liquidity Ratio CRVO|Quick Ratio ATHE (Alterity Therapeutics Limited)|Interim Coverage Ratio Clene Inc (CLNN)|PepGen Corp - Quick Ratio|Jupiter Neurosciences, Inc. (JUNS) - Quick Liquidity Indicator|RLMD: Quick Ratio|Annovis Bio Inc (ANVS) - Quick Ratio|Quick Liquidity Grace Therapeutics Inc|Quick Liquidity AIFF|Quick Liquidity Klotho Neurosciences Inc (KLTO)|Interim Coverage Ratio neurosense-tx.com|Quick Ratio RVPH (Reviva Pharmaceuticals Holdings, Inc.)|Quick Ratio MetaVia Inc. MTVA|NeurAxis, Inc - Quick Ratio|HSDT: Quick Liquidity|passagebio.com (PASG) - Quick Liquidity|Immediate Liquidity Neuphoria Therapeutics (NEUP)|Quick Liquidity Minerva Neurosciences, Inc.|Athira Pharma Inc (ATHA) - Interim Coverage Ratio|Quick Liquidity Addex Therapeutics, Ltd. (ADXN)|alzamend.com - Immediate Liquidity Ratio|Quick Ratio CYCN (Cyclerion Therapeutics, Inc.)|Protagenic Therapeutics Inc. (PTIX) - Immediate Liquidity|KTTA: Quick Liquidity Indicator|CRGT - Quick Ratio|Avenue Therapeutics, Inc (ATXI) - Quick Liquidity|BrainStorm Cell Therapeutics Inc. - Intermediate Coverage Ratio|Quick Liquidity Cara Therapeutics, Inc.|Immediate Liquidity chromocell.com CHRO|Quick Ratio ELYM|Quick Ratio intracellulartherapies.com (ITCI)|Quick Ratio LBPH (Longboard Pharma)|MRNS - Quick Liquidity Indicator|NKGN: Quick Liquidity Indicator|NRBO - Quick Ratio|Sage Therapeutics (SAGE) - Quick Liquidity|Quick Liquidity Indicator Synaptogenix Inc.|TRVN (Trevena, Inc) - Quick Ratio|Immediate Liquidity Vigil Neuro VIGL|Quick Liquidity Anew Medical (WENA)|cerevel.com - Immediate Liquidity Ratio